✦ LIBER ✦

Leukocyte count as a predictor of death during remission induction in acute myeloid leukemia

✍ Scribed by Greenwood, M. J.; Seftel, M. D.; Richardson, C.; Barbaric, D.; Barnett, M. J.; Bruyere, H.; Forrest, D. L.; Horsman, D. E.; Smith, C.; Song, K.; Sutherland, H. J.; Toze, C. L.; Nevill, T. J.; Nantel, S. H.; Hogge, D. E.

Book ID: 121433213
Publisher: Informa plc
Year: 2006
Tongue: English
Weight: 132 KB
Volume: 47
Category: Article
ISSN: 1042-8194
DOI: 10.1080/10428190600572673

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Early blast clearance by remission induc

Early blast clearance by remission induction as a prognostic factor in acute myeloid leukemia

✍ Elihu H. Estey 📂 Article 📅 2003 🏛 Current Science Inc. 🌐 English ⚖ 117 KB

Blood bank leukocyte infusions as remiss

Blood bank leukocyte infusions as remission induction therapy in a case of acute lymphoblastic leukemia

✍ Borbolla, J R; López, M A; Alvarado, M; Guzman, L; DeDiego, J; Trueba, E; Gonzál 📂 Article 📅 1997 🏛 Nature Publishing Group 🌐 English ⚖ 81 KB

Comorbidity is an independent predictor

Comorbidity is an independent predictor of complete remission in elderly patients receiving induction chemotherapy for acute myeloid leukemia

✍ Anne Etienne; Benjamin Esterni; Aude Charbonnier; Marie-Joëlle Mozziconacci; Chr 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 97 KB 👁 2 views

A prognostic analysis of acute leukemia

A prognostic analysis of acute leukemia during remission induction period in Shanghai

✍ Guowei Lin; Jun Wang; Xiaoqin Wang; Qian Wang; Peidi Lin 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 169 KB

Death during induction therapy and first

Death during induction therapy and first remission of acute leukemia in childhood : The St. Jude experience

✍ Jeffrey E. Rubnitz; Shelly Lensing; Yinmei Zhou; John T. Sandlund; Bassem I. Raz 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 119 KB

Impact of remission induction chemothera

Impact of remission induction chemotherapy on survival in older adults with acute myeloid leukemia

✍ Rachid Baz; Cristina Rodriguez; Alex Z. Fu; Rony Abou Jawde; Matt Kalaycio; Anja 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 124 KB 👁 2 views

## Abstract ## BACKGROUND. Significant controversy surrounds the use of remission induction chemotherapy (IC) in older adults with acute myeloid leukemia (AML). Earlier clinical trials have yielded conflicting results and possibly a minor survival benefit, often offset by a longer hospitalization